A doctor in Texas has admitted that he leaked a research paper to the manufacturers of controversial diabetes medication Avandia, shortly before the research was published, crippling the diabetic drug.
The research, now infamous, linked Avandia with higher risks of heart attack . According to scientific journal Nature, Dr. Steven Haffner, of the Health Science Center at University of Texas breached rules by passing the research paper to GlaxoSmithKline Plc.
The study, which caused untold damage to Avandia, linked the drug to a 43 per cent increase in heart attacks. Eventually, the Food and Drug Administration issued a strict safety warning.
Haffner was reported to have faxed a copy of the study to an employee of Glaxo . He reportedly commented: “Why I sent it is a mystery. I don’t really understand it. I wasn’t feeling well. It was bad judgment.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…